EXEL: To Present At Piper Jaffray Health Care Conference @ 11:00 ET [delayed] -
Exelixis Announces December 12 Webcast of Its Fourth Annual R&D Day -
BRIEF-Exelixis and Bristol-Myers Squibb to co-develop XL413 -
EXEL: To Present At Lazard Capital Healthcare Conference @ 15:10 ET [delayed] -
BRIEF-Exelixis says cuts 10 pct of workforce -
BRIEF-Exelixis extends research collaboration with Bristol Myers -
Form 4 Oracle: Boston, MA -- Form4Oracle: Insider Trading Report: Exelixis Inc (EXEL) -
EXEL: To Present At BIO Investor Conference @ 15:00 ET [delayed] -
Exelixis Announces October 30 Webcast of Presentation at the 7th Annual BIO Investor Forum -
EXEL: To Present At BIOCOM Investor Conference @ 15:30 ET [delayed] -
BRIEF-Exelixis retains rights to develop and commercialize XL184 -
Exelixis Will Have 15 Presentations at the 2008 EORTC-NCI-AACR Annual Meeting -
EXEL: To Present At JMP Securities Healthcare Conference @ 11:30 ET [delayed] -
EXEL: Submits IND to FDA for XL888 Oral Anticancer Compound -
Exelixis Files IND Application for XL888 -
EXEL: To Present At BioCentury's Biotech Industry Conference @ 11:00 ET [delayed] -